IRIS Accounts Production v26.1.0.640 08521146 Board of Directors 1.1.25 31.12.25 31.12.25 31.7.26 false true false false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh085211462024-12-31085211462025-12-31085211462025-01-012025-12-31085211462023-12-31085211462024-01-012024-12-31085211462024-12-3108521146ns15:EnglandWales2025-01-012025-12-3108521146ns14:PoundSterling2025-01-012025-12-3108521146ns10:Director12025-01-012025-12-3108521146ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3108521146ns10:SmallEntities2025-01-012025-12-3108521146ns10:Audited2025-01-012025-12-3108521146ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3108521146ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3108521146ns10:AbridgedAccounts2025-01-012025-12-310852114612025-01-012025-12-3108521146ns10:Director22025-01-012025-12-3108521146ns10:CompanySecretary12025-01-012025-12-3108521146ns10:RegisteredOffice2025-01-012025-12-3108521146ns5:CurrentFinancialInstruments2025-12-3108521146ns5:CurrentFinancialInstruments2024-12-3108521146ns5:ShareCapital2025-12-3108521146ns5:ShareCapital2024-12-3108521146ns5:CapitalRedemptionReserve2025-12-3108521146ns5:CapitalRedemptionReserve2024-12-3108521146ns5:RetainedEarningsAccumulatedLosses2025-12-3108521146ns5:RetainedEarningsAccumulatedLosses2024-12-3108521146ns5:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3108521146ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-01-012025-12-3108521146ns5:PlantMachinery2025-01-012025-12-3108521146ns5:FurnitureFittings2025-01-012025-12-3108521146ns5:ComputerEquipment2025-01-012025-12-31
REGISTERED NUMBER: 08521146 (England and Wales)






Financial Statements

for the Year Ended 31 December 2025

for

PHOENIX DOSIMETRY LTD

PHOENIX DOSIMETRY LTD (REGISTERED NUMBER: 08521146)

Contents of the Financial Statements
for the Year Ended 31 December 2025










Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


PHOENIX DOSIMETRY LTD

Company Information
for the Year Ended 31 December 2025







DIRECTORS: W4S Directors Limited
B D Read





SECRETARY: Cossey Cosec Services Limited





REGISTERED OFFICE: 4th Floor
24 Old Bond Street
London
W1S 4AW





REGISTERED NUMBER: 08521146 (England and Wales)





AUDITORS: Pembroke Briggs Chartered Accountants
Beacon House
South Road
Weybridge
Surrey
KT13 9DZ

PHOENIX DOSIMETRY LTD (REGISTERED NUMBER: 08521146)

Abridged Balance Sheet
31 December 2025

31.12.25 31.12.24
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 13,932 -
Tangible assets 5 46,911 58,296
60,843 58,296

CURRENT ASSETS
Stocks 122,138 210,733
Debtors 1,095,579 777,541
Cash at bank 215,455 338,062
1,433,172 1,326,336
CREDITORS
Amounts falling due within one
year

1,016,631

1,004,613
NET CURRENT ASSETS 416,541 321,723
TOTAL ASSETS LESS
CURRENT LIABILITIES

477,384

380,019

CAPITAL AND RESERVES
Called up share capital 50 50
Capital redemption reserve 50 50
Retained earnings 477,284 379,919
SHAREHOLDERS' FUNDS 477,384 380,019

PHOENIX DOSIMETRY LTD (REGISTERED NUMBER: 08521146)

Abridged Balance Sheet - continued
31 December 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 December 2025 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 31 July 2026 and were signed on its behalf by:





B D Read - Director


PHOENIX DOSIMETRY LTD (REGISTERED NUMBER: 08521146)

Notes to the Financial Statements
for the Year Ended 31 December 2025


1. STATUTORY INFORMATION

Phoenix Dosimetry Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of three years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% on cost
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% on cost

Stocks
Stocks and work in progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.


PHOENIX DOSIMETRY LTD (REGISTERED NUMBER: 08521146)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025


2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2024 - 8 ) .

PHOENIX DOSIMETRY LTD (REGISTERED NUMBER: 08521146)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025


4. INTANGIBLE FIXED ASSETS
Totals
£   
COST
Additions 14,244
At 31 December 2025 14,244
AMORTISATION
Amortisation for year 312
At 31 December 2025 312
NET BOOK VALUE

At 31 December 2025 13,932

5. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 January 2025 93,536
Additions 22,855
Disposals (41,598 )
At 31 December 2025 74,793
DEPRECIATION
At 1 January 2025 35,240
Charge for year 13,218
Eliminated on disposal (20,576 )
At 31 December 2025 27,882
NET BOOK VALUE
At 31 December 2025 46,911
At 31 December 2024 58,296

6. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

S Briggs (Senior Statutory Auditor)
for and on behalf of Pembroke Briggs Chartered Accountants

PHOENIX DOSIMETRY LTD (REGISTERED NUMBER: 08521146)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025


7. ULTIMATE CONTROLLING PARTY

The Company's immediate parent company is HTSL Group Limited.

In the Director's opinion there is no one controlling party.